BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 785839)

  • 1. [Summary of work session 1: Blood coagulation in gastroenterology].
    Bredden K; Lechner K
    Z Gastroenterol; 1976 Mar; 14 Suppl():202-10. PubMed ID: 785839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic abnormalities in chronic aggressive hepatitis and liver cirrhosis.
    Ruggiero G; De Biasi R; Attanasio S; Bile G; Giusti G
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):221-8. PubMed ID: 1179944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 May; 100(18):836-40. PubMed ID: 6178666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation].
    Schwick HG; Trobisch H; Heimburger N
    Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New methods in coagulation.
    Triplett DA
    Crit Rev Clin Lab Sci; 1981; 15(1):25-84. PubMed ID: 6459909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic abnormalities and liver diseases.
    Wada H; Usui M; Sakuragawa N
    Semin Thromb Hemost; 2008 Nov; 34(8):772-8. PubMed ID: 19214915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations between the diminished secretion of export proteins from the liver and the plasmatic activity of liver cell enzymes (author's transl)].
    Lautz HU; Schmidt E; Schmidt FW; Barthels M
    Z Gastroenterol; 1979 Feb; 17(2):99-105. PubMed ID: 425591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation abnormalities in liver disease.
    Mammen EF
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1247-57. PubMed ID: 1333467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
    Biland L; Duckert F; Prisender S; Nyman D
    Thromb Haemost; 1978 Jun; 39(3):646-56. PubMed ID: 705694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparinised clotting factor concentrates in patients with Christmas disease and liver disease.
    Preston FE; Malia RG; Lilleyman JS; Blackburn EK
    Thromb Haemost; 1977 Aug; 38(2):504-9. PubMed ID: 579492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic problems in liver surgery.
    Rö JS
    Scand J Gastroenterol Suppl; 1973; 19():71-81. PubMed ID: 4577801
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation abnormalities in liver disease.
    Lechner K; Niessner H; Thaler E
    Semin Thromb Hemost; 1977; 4(1):40-56. PubMed ID: 199944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
    Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
    Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.